[Federal Register: April 24, 2003 (Volume 68, Number 79)]
[Notices]               
[Page 20158-20159]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24ap03-58]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Peripheral and Central Nervous System Drugs Advisory Committee; 
Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is cancelling the 
meeting of the Peripheral and Central Nervous System Drugs Advisory 
Committee scheduled for May 16, 2003. This meeting was announced in the 
Federal Register of April 14, 2003 (68 FR 17958).

FOR FURTHER INFORMATION CONTACT: Karen M. Templeton-Somers, Center for 
Drug Evaluation and Research (HFD-21), Food and Drug Administration, 
5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area) code 12543, or e-mail: SomersK@cder.fda.gov.

[[Page 20159]]


    Dated: April 18, 2003.
Lester M. Crawford,
Deputy Commissioner.
[FR Doc. 03-10150 Filed 4-23-03; 8:45 am]

BILLING CODE 4160-01-S